Primary Care Clinicians
Type 2 Diabetes; primary care; quality improvement
|Name of Faculty||Reported Financial Relationship|
|Carol Wysham, MD|| |
Dr. Wysham has served on Speakers Bureaus for Astra Zeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Insulet, Novo Nordisk and Sanofi. She has served on Advisory Boards for Abbott, Astra Zeneca, Janssen, Novo Nordisk and Sanofi. She has provided services for non-CME promotional purposes for Sanofi and Novo Nordisk.
|Davida F. Kruger, MSN, APN-BC, BC-ADM|| |
Ms. Kruger has served on Advisory Boards for Abbott, Eli Lilly and Company, Janssen, Novo Nordisk, sanofi, Dexcom, Intarcia and Merck.
She has served on Speakers Bureaus for Abbott, Astra Zeneca, Boehringer Ingelhemi/Lilly, Eli Lilly and Company, Janssen, Novo Nordisk, Dexcom, Insulet and Valeritas.
Her institution has received grants/research support from Abbott, Astra Zeneca, Eli Lilly and Company, Novo Nordisk, Dexcom, and Lexicon. Ms. Kruger is a stockholder in Dexcom.
|Felice Caldarella, MD, FACE, FACP, CDE|| |
Dr. Calderella served as External Reviewer for this activity. He discloses no relevant financial relationships with ACCME-defined commercial interests during the past 12 months.
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above